Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07678554 · ClinicalTrials.gov registry record · NA
Overvaluation of Weight and Shape Intervention vs The Body Project
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT07678554: Clinical Trial NA study, sponsored by Stanford University.
NCT07678554 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07678554, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
Priorities aims to reduce body image concerns, prevent eating disorders, bolster self-esteem, and promote mental and emotional health by helping participants identify and nurture alternative sources of self-worth. Priorities would use group discussions, role-plays \& behavioral challenges, homework assignments \& letter-writing, and self-worth activism to achieve this. The Priorities intervention will be compared to The Body Project (an existing and successful harm reduction and eating disorder prevention program) for its effectiveness of reducing body image concerns and eating disorder outcomes. This study aims to evaluate whether there is a more effective eating disorder prevention program than The Body Project.
Primary Outcome
Participants will be surveyed on the following measures before and after the intervention: self-report measure of weight/shape overvaluation, thin-ideal internalization, body dissatisfaction, harms from social media scale and mental health scales, depression questionnaire, anxiety questionnaire, PANAS scale for negative affect, as well as the self-report Eating Disorder Diagnostic Screen (assessing eating disorder symptoms using the Eating Disorder Diagnostic Survey (EDDS), a brief self-report s
Interventions
- BEHAVIORAL Body Project
- BEHAVIORAL Priorities
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2027-06-01 |
| Phase | NA |
What is known before NCT07678554 opens enrollment
NCT07678554 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Body Project is the first listed.
NCT07678554 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07678554 about?
NCT07678554 is a clinical study titled "Overvaluation of Weight and Shape Intervention vs The Body Project". Priorities aims to reduce body image concerns, prevent eating disorders, bolster self-esteem, and promote mental and emotional health by helping participants identify and nurture alternative sources of self-worth. Priorities would use group discussions, role-plays \& behavioral challenges, homework ...
What is the current status of trial NCT07678554?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2026-07-01. Estimated completion is 2027-06-01.
What interventions are being tested in trial NCT07678554?
The interventions under investigation include: Body Project (BEHAVIORAL), Priorities (BEHAVIORAL).
Who is sponsoring clinical trial NCT07678554?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07678554's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI